Related Experiment Video
Updated: Oct 13, 2026

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
Published on: January 19, 2019
[Experimental studies on the enhancing effects of the combined therapy with tegafur and cytochrome C]
Abstract:
Coadministration of Tegafur and cytochrome C produced higher concentration of an active substance, 5-FU, in the blood of normal rats as compared with Tegafur alone. However, there was no difference between the combination regimen and Tegafur alone in LD50. Blood and tumor levels of 5-FU in tumor-bearing rats were higher in the combination than Tegafur alone, and survival effects were more favorable in the former. On the other hand, cytochrome C prohibited decrease in the amount of liver P-450 induced by carbon tetrachloride.
Related Concept Videos
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

